Deanna L. Pratt

Array ( [id] => 5769045 [patent_doc_number] => 20060019894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Use of factor VIIa or factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage' [patent_app_type] => utility [patent_app_number] => 11/169933 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8007 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019894.pdf [firstpage_image] =>[orig_patent_app_number] => 11169933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715614 [patent_doc_number] => 20060078977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Novel purified polypeptides from Enterococcus faecalis' [patent_app_type] => utility [patent_app_number] => 11/167900 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 236 [patent_figures_cnt] => 236 [patent_no_of_words] => 67820 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078977.pdf [firstpage_image] =>[orig_patent_app_number] => 11167900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676197 [patent_doc_number] => 20080213827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Process For Producing Dipeptides or Dipeptide Derivatives' [patent_app_type] => utility [patent_app_number] => 11/630397 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33383 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213827.pdf [firstpage_image] =>[orig_patent_app_number] => 11630397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591404 [patent_doc_number] => 20060040856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Glycopegylated factor IX' [patent_app_type] => utility [patent_app_number] => 11/166028 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31079 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040856.pdf [firstpage_image] =>[orig_patent_app_number] => 11166028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769044 [patent_doc_number] => 20060019893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Factor VIIa variants' [patent_app_type] => utility [patent_app_number] => 11/159647 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19712 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019893.pdf [firstpage_image] =>[orig_patent_app_number] => 11159647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 836859 [patent_doc_number] => 07393674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Thrombin compositions' [patent_app_type] => utility [patent_app_number] => 11/157707 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4825 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393674.pdf [firstpage_image] =>[orig_patent_app_number] => 11157707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7053752 [patent_doc_number] => 20050274924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Nucleic acid sequences encoding type III Tenebrio antifreeze proteins and method for assaying activity' [patent_app_type] => utility [patent_app_number] => 11/156909 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 131 [patent_figures_cnt] => 131 [patent_no_of_words] => 89940 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20050274924.pdf [firstpage_image] =>[orig_patent_app_number] => 11156909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734576 [patent_doc_number] => 20080051556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods' [patent_app_type] => utility [patent_app_number] => 11/153918 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31534 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051556.pdf [firstpage_image] =>[orig_patent_app_number] => 11153918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676249 [patent_doc_number] => 20080213879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level' [patent_app_type] => utility [patent_app_number] => 11/149177 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18476 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213879.pdf [firstpage_image] =>[orig_patent_app_number] => 11149177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880508 [patent_doc_number] => 20060029590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Administration of neutral endopeptidase to treat inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 11/149513 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14475 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029590.pdf [firstpage_image] =>[orig_patent_app_number] => 11149513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632225 [patent_doc_number] => 20060148695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Novel angiogenic composition and use thereof' [patent_app_type] => utility [patent_app_number] => 11/149378 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8164 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148695.pdf [firstpage_image] =>[orig_patent_app_number] => 11149378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199933 [patent_doc_number] => 20070299251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Isolation of Plasma or Serum Proteins' [patent_app_type] => utility [patent_app_number] => 11/570154 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 47060 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299251.pdf [firstpage_image] =>[orig_patent_app_number] => 11570154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 344960 [patent_doc_number] => 07498146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Stable factor VIII/von willebrand factor complex' [patent_app_type] => utility [patent_app_number] => 11/132326 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9356 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498146.pdf [firstpage_image] =>[orig_patent_app_number] => 11132326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5303456 [patent_doc_number] => 20090298108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Method for Identifying PDE11 Modulators' [patent_app_type] => utility [patent_app_number] => 11/884766 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8594 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298108.pdf [firstpage_image] =>[orig_patent_app_number] => 11884766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4554805 [patent_doc_number] => 07820789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Mutant pneumolysin proteins' [patent_app_type] => utility [patent_app_number] => 11/568802 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13059 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820789.pdf [firstpage_image] =>[orig_patent_app_number] => 11568802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903286 [patent_doc_number] => 07335634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Use of plasma proteins concentrates containing VWF with a high proportion of high molecular weight multimers' [patent_app_type] => utility [patent_app_number] => 11/121046 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2824 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335634.pdf [firstpage_image] =>[orig_patent_app_number] => 11121046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7178862 [patent_doc_number] => 20050204406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Human coagulation factor VII variants' [patent_app_type] => utility [patent_app_number] => 11/111072 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11216 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20050204406.pdf [firstpage_image] =>[orig_patent_app_number] => 11111072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7178886 [patent_doc_number] => 20050204411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Human coagulation factor VII polypeptides' [patent_app_type] => utility [patent_app_number] => 11/111079 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15538 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20050204411.pdf [firstpage_image] =>[orig_patent_app_number] => 11111079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 819996 [patent_doc_number] => 07407475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Modified annexin proteins, and methods and compositions for using them' [patent_app_type] => utility [patent_app_number] => 11/110306 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14190 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407475.pdf [firstpage_image] =>[orig_patent_app_number] => 11110306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894364 [patent_doc_number] => 20060002903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Anti-inflammatory conformal barriers for cell transplantation' [patent_app_type] => utility [patent_app_number] => 11/091939 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 26049 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002903.pdf [firstpage_image] =>[orig_patent_app_number] => 11091939 [rel_patent_id] =>[rel_patent_doc_number] =>)